Who bought quotient bioresearch? Pharmaron Acquires Quotient Bioresearch. BEIJING, February 4, 2016 – Pharmaron, a fully integrated contract research organization (CRO) offering laboratory and manufacturing services for pharmaceutical and biotech research and development, today announced that it acquired Quotient Bioresearch (Quotient).What does quotient sciences do for a living? About Quotient Sciences. Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world. We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry.What does quotient limited qtnt do? JERSEY, Channel Islands, 12 January 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced it has been named a winner in the prestigious 2021 BIG Innovation Awards presented by the Business Intelligence Group.Why choose quotient as your cdmo? At Quotient, we’ve streamlined the drug development process by providing pre-formulation screening, formulation development, first-in-human trials, and clinical & commercial manufacturing services all at one CDMO, allowing us to support drug programs from candidate selection through commercial supply.
Members of Quotient Bioresearch branch are are experts in their field, located in Cardiff in world-class facilities. The branch is respected by management despite there not being a formal recognition agreement in place. Regular meetings are held with management, consultation takes place on matters such as pay and terms and conditions.